Several neurodegenerative disorders are caused by aggregates of a single protein known as alpha-synuclein. In collaboration with CNRS and the University of Antwerp, KU Leuven neurobiologists have discovered that the shape ...
Jun 10, 2015
1
448
After Alzheimer's, Parkinson's is the most common neurodegenerative disease in the world. More than six million people worldwide suffer from it. In this disease, alpha-synuclein proteins form thread-like structures called ...
Nov 15, 2022
0
980
A new Parkinson's disease clinical trial with patients wearing laser light helmets has shown "promising results," as the therapy helped "improve motor function" for those facing the progressive neurological condition.
Apr 28, 2023
0
9
While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats. ...
Apr 3, 2020
1
106
Johns Hopkins Medicine researchers say they have added to evidence that the compound farnesol, found naturally in herbs, and berries and other fruits, prevents and reverses brain damage linked to Parkinson's disease in mouse ...
Jul 28, 2021
0
1063
Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson's disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, ...
Jun 15, 2020
0
209
A molecule that shows promise in preventing Parkinson's disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
Dec 9, 2021
0
290
Hearing loss and epilepsy are early features of Parkinson's, according to pioneering new research from Queen Mary University of London—the first UK study of the condition in such a diverse population, published today in ...
Mar 7, 2022
0
122
For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel ...
Jul 5, 2016
0
1028
Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson's disease. Preclinical tests show that the new treatment approach is not only safe ...
Apr 1, 2022
0
45
